Melvin A Goodman Md is categorized under Internal Medicine Doctors in Beverly Hills, CA and active since 1963.
Melvin A Goodman Md was established in 1963, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Melvin A Goodman at the company’s single location by writing to 465 North Roxbury Drive # 703, Beverly Hills, California CA 90210 or by phoning (310) 550-8052. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Melvin A Goodman Md |
| Contact Person: | Melvin A Goodman |
| Address: | 465 North Roxbury Drive # 703, Beverly Hills, California 90210 |
| Phone Number: | (310) 550-8052 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1963 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Melvin A Goodman Md was started in 1963 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Melvin A Goodman for inquiries that concern Melvin A Goodman Md by calling the company number (310) 550-8052, as your correspondence is most welcome. Additionally, the physical location of the single location of Melvin A Goodman Md can be found at the coordinates 34.068348,-118.407402 as well as the street address 465 North Roxbury Drive # 703 in Beverly Hills, California 90210.
For its online presence, you may visit Melvin A Goodman Md’s website at and engage with its social media outlets through on Twitter and on Facebook.